Alcohol consumption and atherosclerosis: What is the relation?: Prospective results from the Bruneck Study

Stroke

Volumn 29, Issue 5, 1998, Pages 900-907

  Kiechl, Stefan ^a   Willeit, Johann ^a   Rungger, Gregor ^d   Egger, Georg ^b   Oberhollenzer, Friedrich ^b   Bonora, Enzo ^c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b BRUNECK HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Innsbruck University Hospital ^*

Author keywords

Alcohol drinking; Atherosclerosis; Carotid artery disease; Lipid peroxidation; Lipoproteins, LDL

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0031971817     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.5.900     Document Type: Article

References (51)

1. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986;124:481-489.
2. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993;15:328-351.
3. Rimm EB, Giovannucci FL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet. 1991;338:464-468.
4. Camargo CA Jr. Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke. 1989;20:1611-1626.
5. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997;157:79-85.
6. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol. BMJ. 1994;309:911-918.
7. Kiechl S, Willeit J, Egger G, Oberhollenzer M, Aichner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects: results from the Bruneck study. Stroke. 1994;25:1593-1598.
8. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ. 1996; 312:736-741.
9. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb. 1993;13:661-668.
10. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
11. World Health Organization. Measuring Obesity: Classification and Description of Anthropometric Data. Copenhagen, Denmark: WHO Regional Office for Europe, Nutrition Unit: 1988.
12. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Circulation. 1997;96:3300-3307.
13. Landis JR, Koch GG. Measurements of observer agreement for categorical data. Biometrics. 1977;33:159-174.
14. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1988.
15. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040-1044.
16. Demirovic J, Nabulsi A, Folsom AR, Carpenter MA, Szklo M, Sorlie PD, Barnes RW. Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. Circulation. 1993;88: 2787-2793.
17. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992;85:910-915.
18. Bogousslavsky J, Van Melle G, Despland PA, Regli F. Alcohol consumption and carotid atherosclerosis in the Lausanne Stroke Registry. Stroke. 1990;21:715-720.
19. Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men: 20-year findings from the Honolulu Heart Program. Arch Intern Med. 1995;155:686-694.
20. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi f, Feruglio GA, Touboul PJ. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
21. Steinberg D, Pearson TA, Kuller LH. Alcohol and atherosclerosis. Ann Intern Med. 1991;114:967-976.
22. Poikolainen K. Alcohol and mortality. J Clin Epidemiol. 1995;48: 455-465.
23. Veenstra J, Ockhuizen T, Van de Pol H, Wedel M, Schaafsma G. Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. Alcohol Alcoholism. 1990;25:371-377.
24. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet. 1994;344:1719-1723.
25. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267-273.
26. Anon. Inhibition of LDL oxidation by phenolic substances in red wine: a clue to the French paradox? Nutr Rev. 1993;51:185-187.
27. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454-457.
28. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci. 1996;91:449-458.
29. Shahidi F, Wanasundara PKJ. Phenolic antioxidants. Crit Rev Food Sci Nutr. 1992;32:67-103.
30. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549-554.
31. Halliwell B. Antioxidants in wine. Lancet. 1993;341:1538. Letter.
32. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182-1188.
33. Das NP. Studies on flavonoid metabolism: absorption and metabolism of (+)-catechin in man. Biochem Pharmacol. 1971;20:3435-3445.
34. Bjorneboe A, Bjorneboe GE. Antioxidant status and alcohol-related diseases. Alcohol Alcoholism. 1993;28:111-116.
35. Shaish A, Pape M, Rea T, Srivastava RAK, Latour MA, Hopkins D, Schonfeld G. Alcohol increases plasma levels of cholesterol, diet-induced atherogenic lipoproteins, and aortic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:1091-1097.
36. Kesäniemi YA, Kervinen K, Miettinen TA. Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man. Eur J Clin Invest. 1987;17:29-36.
37. Dicker E, Cederbaum AI. Increased NADH-dependent production of reactive oxygen intermediates by microsomes after chronic ethanol consumption. Arch Biochem Biophysiol. 1992;293:274-280.
38. Shaw S, Jayatilleke E. Ethanol-induced iron mobilization: role of acetaldehyde-aldehyde oxidase generated superoxide. Free Radic Biol Med. 1990;9:11-17.
39. Croft KD, Puddey IB, Rakic V, Abu-Amsha R, Dimmitt SB, Beilin LJ. Oxidative susceptibility of low density lipoproteins: influence of regular alcohol use. Clin Exp Res. 1996;20:980-984.
40. 2 synthesis, platelet aggregation and platelet thromboxane release. BMJ. 1983;287:1495-1498.
41. Renaud S, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr. 1992;55:1012-1017.
42. Ridker PM, Vaughan DE, Stampfer MJ, Glyn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994;272: 929-933.
43. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ. 1979;278:153-156.
44. Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med. 1974;56:22-33.
45. Veenestra J, Wierik E, Kluft C. Alcohol and fibrinolysis. Fibrinolysis. 1990;4(suppl):64-68.
46. Landolfi R, Steiner M. Ethanol raises prostacyclin in vivo and in vitro. Blood. 1984;64:679-682.
47. Nordoy A, Lagarde M, Renaud S. Platelets during hyperlipidaemia induced by cream and cod liver oil. Eur J Clin Invest. 1984;14:339-345.
48. Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats: relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol. 1995;15:140-144.
49. Desai K, Owen JS, Wilson DT, Hutton RA. Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal. Thromb Haemost. 1986;56:173-177.
50. Alanko T. An overview of techniques and problems in the measurement of alcohol consumption. In: Smart RG, Capell HD, Glaser FB, eds. Research Advances in Alcohol and Drug Problems. New York, NY: Plenum Publishing Corp; 1984:209-226.
51. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2:1267-1273.